Literature DB >> 20421781

Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens.

Gladell P Paner1, Jeffrey G Brown, Shawn Lapetino, Nalan Nese, Ruta Gupta, Steven S Shen, Donna E Hansel, Mahul B Amin.   

Abstract

Accurate recognition of muscularis propria invasion by urothelial carcinoma is vital as it serves as a crossroad between conservative and aggressive clinical management. Recently, there has been attention to the hyperplastic pattern of muscularis mucosae which may mimic the muscularis propria. We have earlier shown that smoothelin, a marker of terminally differentiated smooth muscle cells, is relatively specific for muscularis propria (positive staining) and is variably negative to weak in muscularis mucosae. The earlier study was based on cystectomy specimen slides in which the bladder cancer was not present. Pathologic staging in transurethral resection of urinary bladder tumor (TURBT) specimens is complicated by limited, unoriented, or highly cauterized samples. Herein, we test the capability of smoothelin to recognize muscularis propria in TURBT specimens to further substantiate its diagnostic applicability in routine practice. Representative sections from 70 TURBTs were immunostained with smoothelin, and muscularis propria was evaluated in H&E slides and the corresponding smoothelin immunohistochemistry slides using double-blinded analysis. In 31/70 (44%) cases, muscularis propria was involved by invasive carcinoma. Cautery artifact was present in 46/70 (66%) cases, which did not seem to affect smoothelin immunohistochemistry staining of the muscularis propria. Muscularis propria was present by H&E in 48/70 (69%) cases and 48/70 (69%) cases had muscularis propria by smoothelin immunohistochemistry-based 2 (+) or 3 (+) positivity in larger muscle bundles with round regular contours. Desmoplastic response to invasive carcinoma stained negatively for smoothelin. The sensitivity, specificity, positive predictive value, and negative predictive value of smoothelin based on comparison with morphology in TURBT specimens was 98%, 95%, 98%, and 95%, respectively. This study confirms the relatively high sensitivity and specificity for smoothelin in MP, including in TURBT specimens. Immunoreactivity is retained despite the presence of thermal tissue injury, desmoplasia, or involvement by carcinoma. Our data confirm the use of smoothelin in the accurate distinction between muscularis propria and muscularis mucosae or desmoplastic reactions, thereby facilitating appropriate pathologic stage designation in often challenging TURBT specimens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421781     DOI: 10.1097/PAS.0b013e3181da7650

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

1.  Detection of smoothelin expression in the urinary bladder is strongly dependent on pretreatment conditions: a critical analysis with possible consequences for cancer staging.

Authors:  Claes Lindh; Robert Nilsson; Marie Louise Lindstrom; Lilian Lundin; Goran Elmberger
Journal:  Virchows Arch       Date:  2011-04-15       Impact factor: 4.064

2.  Cautery artifact understages urothelial cancer at initial transurethral resection of large bladder tumours.

Authors:  Matthew Truong; Lorraine Liang; Janet Kukreja; Jeanne O'Brien; Jerome Jean-Gilles; Edward Messing
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

3.  Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.

Authors:  Margaret Lawless; Roman Gulati; Maria Tretiakova
Journal:  Histopathology       Date:  2017-06-27       Impact factor: 5.087

4.  Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens.

Authors:  Michael J Hwang; Ashish M Kamat; Colin P Dinney; Bogdan Czerniak; Charles C Guo
Journal:  Am J Clin Pathol       Date:  2020-07-07       Impact factor: 2.493

5.  Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?

Authors:  Willemien Beukers; Titia Meijer; Cornelis J Vissers; Joost L Boormans; Ellen C Zwarthoff; Geert J L H van Leenders
Journal:  Virchows Arch       Date:  2012-07-10       Impact factor: 4.064

6.  Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.

Authors:  Carlo Patriarca; Rodolfo Hurle; Marco Moschini; Massimo Freschi; Piergiuseppe Colombo; Maurizio Colecchia; Lucia Ferrari; Giorgio Guazzoni; Andrea Conti; Giario Conti; Roberta Lucianò; Tiziana Magnani; Renzo Colombo
Journal:  Diagn Pathol       Date:  2016-01-20       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.